Dr. Reddy's Laboratories Limited has informed the Exchange about press release dated 27-Jul-2022 titled Dr. Reddy's Laboratories announces the launch of Bortezomib for Injection, 3.5 mg Single-Dose Vial in the U.S. Market
Press Release Jul 27 2022
Filed with NSE ·
Watch Dr. Reddy's Laboratories' latest callDr. Reddy's Laboratories (NSE:DRREDDY) Q1 2027 Earnings Call · Replay · Jul 22Read the transcript of Dr. Reddy's Laboratories (NSE:DRREDDY) Q1 2027 Earnings Call6ix hasn’t read this filing yet.
Dr. Reddy's Laboratories Ltd. on 6ix
In the deck
Earlier from Dr. Reddy's Laboratories
- Press Release Jul 22 2022
- Press Release Jul 08 2022
- Press Release Jun 28 2022
- Press Release Jun 24 2022
- Dr. Reddy's Laboratories Announces the Acquisition of an Injectable Product Portfolio from Eton Pharma
Later from Dr. Reddy's Laboratories
- Press Release Sep 07 2022
- Press Release Oct 11 2022
- Press Release Dec 16 2022
- Press Release Dec 19 2022
- Press Release Jan 13 2023
Follow Dr. Reddy's Laboratories into a list and get an email when it puts out news.
Follow Dr. Reddy's Laboratories